China Universal Asset Management Co., Ltd. Travere Therapeutics, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 18,206 shares of TVTX stock, worth $400,167. This represents 0.03% of its overall portfolio holdings.
Number of Shares
18,206
Previous 14,712
23.75%
Holding current value
$400,167
Previous $205,000
54.63%
% of portfolio
0.03%
Previous 0.02%
Shares
15 transactions
Others Institutions Holding TVTX
# of Institutions
213Shares Held
94.1MCall Options Held
1.2MPut Options Held
778K-
Black Rock Inc. New York, NY7.64MShares$168 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.36MShares$162 Million1.81% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.74MShares$148 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.97MShares$109 Million3.46% of portfolio
-
Macquarie Group LTD Australia, C34.26MShares$93.6 Million0.09% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.41B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...